Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate

Mohamed, Kamel; Davies, William A.; Lashen, Hany

doi:10.1016/j.fertnstert.2006.03.047

Cited by 54 publications

(27 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One of most attractive advantages of AMH is that its levels have been shown to be stable under various influences such as hormonal contraception [38,39], GnRH agonist [40], pregnancy [41], and the menstrual cycle [42][43][44][45]. Therefore, measurements can be made anytime during the menstrual cycle.…”

Section: Discussionmentioning

confidence: 99%

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients

Chen²,

Wu³

et al. 2009

J Assist Reprod Genet

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients

Chen²,

Wu³

et al. 2009

J Assist Reprod Genet

View full text Add to dashboard Cite

show abstract

“…9 On the other hand, gonadotropinreleasing hormone (GnRH) agonists do not seem to affect AMH concentrations. 10 Finally, there are no racial differences in the hormone levels between women of comparable age.…”

Section: Amh: Production Levels and Actions In Womenmentioning

confidence: 98%

The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology

Karkanaki¹,

Vosnakis²,

Panidis³

2011

View full text Add to dashboard Cite

Anti-Müllerian hormone (AMH) is a homodimeric glycoprotein, a member of the transforming growth factor-β superfamily. Over the last decade, a large number of studies examining the multiple roles of AMH have been published. AMH levels accurately reflect the ovarian follicular reserve and could, therefore, be considered as an extremely sensitive marker of ovarian aging and a valuable tool in the diagnosis and the recognition of recurrence of granulosa cell tumors. Furthermore, AMH evaluation is of clinical importance in predicting the success of in vitro fertilization (IVF). Additionally, AMH could be a surrogate diagnostic marker of polycystic ovary syndrome in cases in which ultrasonographic examination is not possible. This article is a review of the clinical usefulness of AMH evaluation in the fields of gynecological endocrinology, menopause, gynecological oncology and assisted reproduction. Special reference is made to the possible implications of AMH in the pathogenesis of polycystic ovary syndrome and the relationship between AMH and obesity.

show abstract

“…Further supporting the contention that AMH is FSH independent (within the limits of FSH fluctuations encountered clinically), exogenous FSH administered to women who regularly ovulate (9) or have polycystic ovary syndrome (10) did not alter plasma AMH levels. Likewise, prolonged suppression of gonadotropins by GnRH-a failed to affect circulating levels of AMH (11).…”

mentioning

confidence: 94%

Clinical uses of anti-Müllerian hormone assays: pitfalls and promises

Streuli

Fraisse

Chapron

et al. 2009

Fertility and Sterility

View full text Add to dashboard Cite

Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate

Cited by 54 publications

References 19 publications

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients

The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology

Clinical uses of anti-Müllerian hormone assays: pitfalls and promises

Contact Info

Product

Resources

About